Resumen acción NATHBIOGEN
Nath Bio-Genes (India) Limited se dedica a la producción, transformación y comercialización de semillas híbridas y modificadas genéticamente en India y a escala internacional.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Recompensas
Análisis de riesgos
Competidores de Nath Bio-Genes (India) Limited
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | ₹195.70 |
| 52 Week High | ₹244.60 |
| 52 Week Low | ₹150.40 |
| Beta | 1.29 |
| 1 Month Change | 9.12% |
| 3 Month Change | -9.27% |
| 1 Year Change | 27.83% |
| 3 Year Change | -42.68% |
| 5 Year Change | -57.99% |
| Change since IPO | 831.90% |
Noticias y actualizaciones recientes
Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has More To Do To Multiply In Value Going Forward
Apr 05
Returns On Capital At Nath Bio-Genes (India) (NSE:NATHBIOGEN) Have Hit The Brakes
Oct 24Recent updates
Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has More To Do To Multiply In Value Going Forward
Apr 05Returns On Capital At Nath Bio-Genes (India) (NSE:NATHBIOGEN) Have Hit The Brakes
Oct 24Nath Bio-Genes (India) (NSE:NATHBIOGEN) Seems To Use Debt Quite Sensibly
Aug 05Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has Some Way To Go To Become A Multi-Bagger
Jun 07Some Investors May Be Worried About Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Returns On Capital
Feb 11We Think Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Taking Some Risk With Its Debt
Aug 27Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Returns On Capital Not Reflecting Well On The Business
Jun 19Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has A Pretty Healthy Balance Sheet
Feb 24Returns On Capital Signal Tricky Times Ahead For Nath Bio-Genes (India) (NSE:NATHBIOGEN)
May 27Is Nath Bio-Genes (India) (NSE:NATHBIOGEN) A Risky Investment?
Feb 28The Trends At Nath Bio-Genes (India) (NSE:NATHBIOGEN) That You Should Know About
Feb 07Declining Stock and Decent Financials: Is The Market Wrong About Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)?
Jan 19The Nath Bio-Genes (India) (NSE:NATHBIOGEN) Share Price Is Up 149% And Shareholders Are Boasting About It
Jan 01Why Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) CEO Pay Matters
Dec 14
These 4 Measures Indicate That Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Using Debt Reasonably Well
Nov 26Here's What To Make Of Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Returns On Capital
Nov 05Do Its Financials Have Any Role To Play In Driving Nath Bio-Genes (India) Limited's (NSE:NATHBIOGEN) Stock Up Recently?
Oct 15Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) Might Not Be As Mispriced As It Looks After Plunging 25%
Sep 24Many Still Looking Away From Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)
Sep 08Introducing Nath Bio-Genes (India) (NSE:NATHBIOGEN), The Stock That Soared 311% In The Last Five Years
Sep 07Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) Doing What It Can To Lift Shares
Aug 18Here's What We Think About Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) CEO Pay
Jul 26Is Nath Bio-Genes (India) (NSE:NATHBIOGEN) Likely To Turn Things Around?
Jul 09Rentabilidad de los accionistas
| NATHBIOGEN | IN Food | Mercado IN | |
|---|---|---|---|
| 7D | 2.2% | -0.3% | -0.03% |
| 1Y | 27.8% | 24.3% | 46.9% |
Rentabilidad frente al sector: NATHBIOGEN superó al sector Indian Food , que obtuvo un rendimiento del 24.7% el año pasado.
Rentabilidad vs. Mercado: NATHBIOGEN obtuvo unos resultados inferiores a los del mercado Indian, que fue del 49% el año pasado.
Volatilidad de los precios
| NATHBIOGEN volatility | |
|---|---|
| NATHBIOGEN Average Weekly Movement | 6.0% |
| Food Industry Average Movement | 7.0% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Precio estable de las acciones: NATHBIOGEN no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de NATHBIOGEN (6%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1979 | 433 | Satish Kagliwal | nathbiogenes.com |
Nath Bio-Genes (India) Limited se dedica a la producción, transformación y comercialización de semillas híbridas y modificadas genéticamente en la India y a escala internacional. Opera en dos segmentos, Actividades Agrícolas y Actividades Comerciales. La empresa ofrece semillas oleaginosas y de fibra, como algodón y mostaza; semillas para cultivos de campo, como bajra, maíz, arroz, trigo y jowar; semillas frutales; y semillas para hortalizas, como guindilla, okra, tomate, berenjena, calabaza de botella, calabaza amarga, calabaza esponja, calabaza de cresta, pepino, cilantro, cebolla, guisante de olor, guisantes verdes, calabaza, tinda, col y judías verdes.
Resumen de fundamentos de Nath Bio-Genes (India) Limited
| Estadísticas fundamentales de NATHBIOGEN | |
|---|---|
| Capitalización bursátil | ₹3.72b |
| Beneficios(TTM) | ₹374.37m |
| Ingresos (TTM) | ₹3.35b |
9.9x
Ratio precio-beneficio (PE)1.1x
Ratio precio-ventas (PS)¿Está NATHBIOGEN sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de NATHBIOGEN | |
|---|---|
| Ingresos | ₹3.35b |
| Coste de los ingresos | ₹1.05b |
| Beneficio bruto | ₹2.30b |
| Otros gastos | ₹1.93b |
| Beneficios | ₹374.37m |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 19.70 |
| Margen bruto | 68.73% |
| Margen de beneficio neto | 11.19% |
| Ratio deuda/patrimonio | 18.7% |
¿Cómo se ha desempeñado NATHBIOGEN a largo plazo?
Ver rendimiento histórico y comparativa